We are the world's first and largest nonprofit biotech 100% focused on developing treatments for ALS.
Scroll to Learn More
Stephen Heywood was diagnosed with ALS at age 29. After finding no treatment options, his brother, James Allen
Heywood, realized that a gap existed in the preclinical development of therapeutics for ALS. In 1999, he
founded the ALS Therapy Development Institute in the basement of his family’s Newton, MA home to bring
effective treatments to people living with ALS as quickly as possible. Although Stephen is no longer with us,
this same sense of hope and family drives every decision made at the Institute today.
The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. We
are the world's first and largest nonprofit biotech focused 100 percent on ALS research. Led by people living
with ALS and their families, we understand the urgent need to slow and stop this disease.
Schedule a tour
Meet the team
The research ALS TDI is doing will, in my opinion, bring us closer to a cure than anything else going on.
We have met the people who work at ALS TDI and their passion shines through, their personal connections to this disease drive them. We believe they are one of the most progressive and effective insitutes around, and they will be part of the cure.
I support ALS TDI because of the Institute's single-minded focus on finding a solution for ALS, and doing so as a nonprofit biotech company with top-tier talent. Clear Objective + Solid Strategy + Stellar People = Desired Results.